Abstract
Limited data are available in elderly patients, as most of the trials excluded old patients older than 70 years. Uncertainty about benefits and risks of invasive treatments are more pronounced in the setting of a very advanced age and concomitant acute coronary syndrome (ACS). This retrospective,
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
